ArticleWorld journal of hepatology2022

Real-life multi-center retrospective analysis on nivolumab in difficult-to-treat patients with advanced hepatocellular carcinoma.

Nika De Wilde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.